Sensei Biotherapeutics, Inc. - Common Stock (SNSE)
0.4410
-0.0040 (-0.90%)
Sensei Biotherapeutics Inc is a biotechnology company focused on developing innovative therapies for cancer and other serious diseases
The company leverages its proprietary platform to create personalized medicine approaches that harness the power of the immune system to target and combat tumors. By utilizing advanced science and technology, Sensei aims to transform the treatment landscape for patients through the development of novel immune-oncology solutions, with a commitment to improving clinical outcomes and enhancing patient quality of life.
Gainers Carbon Revolution Public Limited (NASDAQCREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp.
